Alexion Pharmaceuticals, Inc.
Clinical trials sponsored by Alexion Pharmaceuticals, Inc., explained in plain language.
-
Promising kidney drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called ALXN2050 in 100 adults with kidney inflammation caused by lupus or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. Participants took the drug or a placebo for up to 50 weeks. The trial was stop…
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Ulcerative colitis drug trial halted early
Disease control TerminatedThis study tested a drug called bertilimumab in 32 adults with moderate to severe ulcerative colitis, a condition causing inflammation in the colon. Participants received either the drug or a placebo, and researchers measured changes in disease activity using a scoring system. Th…
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Kidney disease drug trial stopped early: what we learned
Disease control TerminatedThis study tested a drug called ravulizumab in 123 adults with kidney inflammation caused by lupus or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. The trial was terminated early, but the results may still help researchers …
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Eye disease drug trial halted: danicopan fails to slow vision loss?
Disease control TerminatedThis study tested a drug called danicopan in 365 people with geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. The goal was to see if different doses could slow the growth of these spots over two years. The trial was stopped early, s…
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 04, 2026 16:23 UTC